N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders
Clinical trial NCT02200770 · COMPLETED
Trial details
- NCT number
- NCT02200770
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2018-10-26
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.